Consensus Statement on Proton Therapy for Prostate Cancer

Consensus Statement on Proton Therapy for Prostate Cancer

Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective...

Full description

Bibliographic Details
Main Authors: Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:International Journal of Particle Therapy
Subjects:
prostate cancer
radiation therapy
proton therapy
particle therapy
Online Access:https://theijpt.org/doi/pdf/10.14338/IJPT-20-00031.1

Internet

https://theijpt.org/doi/pdf/10.14338/IJPT-20-00031.1

Similar Items